Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products. [electronic resource]
- Journal of medical toxicology : official journal of the American College of Medical Toxicology 12 2017
- 303-308 p. digital
Publication Type: Journal Article
1937-6995
10.1007/s13181-017-0622-8 doi
Acetaminophen--adverse effects Acetylcysteine--therapeutic use Adolescent Adult Analgesics, Non-Narcotic--adverse effects Chemical and Drug Induced Liver Injury--drug therapy Databases, Factual Drug Approval--legislation & jurisprudence Drug Combinations Drug Compounding Drug Overdose--drug therapy Drug and Narcotic Control--legislation & jurisprudence Female Humans Male Middle Aged Naloxone--therapeutic use Narcotic Antagonists--adverse effects Poison Control Centers Policy Making Pregnancy Prescription Drugs--adverse effects Program Evaluation Protective Factors Risk Factors Time Factors United States United States Food and Drug Administration--legislation & jurisprudence Young Adult